253 related articles for article (PubMed ID: 28760618)
1. Control of vertigo in Ménière's disease by intratympanic dexamethasone.
Weckel A; Marx M; Esteve-Fraysse MJ
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Feb; 135(1):7-10. PubMed ID: 28760618
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
Öztürk K; Ata N
Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
[TBL] [Abstract][Full Text] [Related]
4. Control of vertigo after intratympanic corticoid therapy for unilateral Ménière's disease: a comparison of weekly versus daily fixed protocols.
Martin Sanz E; Zschaeck C; Gonzalez M; Mato T; Rodrigañez L; Barona R; Sanz R
Otol Neurotol; 2013 Oct; 34(8):1429-33. PubMed ID: 23722456
[TBL] [Abstract][Full Text] [Related]
5. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
Garduño-Anaya MA; Couthino De Toledo H; Hinojosa-González R; Pane-Pianese C; Ríos-Castañeda LC
Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic steroids for Ménière's disease or syndrome.
Phillips JS; Westerberg B
Cochrane Database Syst Rev; 2011 Jul; (7):CD008514. PubMed ID: 21735432
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic Triamcinolone and Dexamethasone in the Treatment of Ménière's Syndrome.
Jumaily M; Faraji F; Mikulec AA
Otol Neurotol; 2017 Mar; 38(3):386-391. PubMed ID: 28192380
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
10. Intratympanic steroid injections for intractable Ménière's disease.
Barrs DM; Keyser JS; Stallworth C; McElveen JT
Laryngoscope; 2001 Dec; 111(12):2100-4. PubMed ID: 11802004
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease.
She W; Lv L; Du X; Li H; Dai Y; Lu L; Ma X; Chen F
J Laryngol Otol; 2015 Mar; 129(3):232-7. PubMed ID: 25655232
[TBL] [Abstract][Full Text] [Related]
12. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients.
Atrache Al Attrache N; Krstulovic C; Pérez Guillen V; Morera Pérez C; Pérez Garrigues H
J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
Beyea JA; Instrum RS; Agrawal SK; Parnes LS
Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
[TBL] [Abstract][Full Text] [Related]
14. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of endolymphatic sac shunting with local steroids for Meniere's disease.
Wick CC; Manzoor NF; McKenna C; Semaan MT; Megerian CA
Am J Otolaryngol; 2017; 38(3):285-290. PubMed ID: 28214024
[TBL] [Abstract][Full Text] [Related]
16. Transitory effect on endolymphatic hydrops of the intratympanic steroids for Ménière's disease.
Martin-Sanz E; Esteban-Sanchez J; Rodrigañez-Riesco L; Sanz-Fernández R
Laryngoscope; 2015 May; 125(5):1183-8. PubMed ID: 25429741
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
18. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
Shea PF; Richey PA; Wan JY; Stevens SR
Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
[TBL] [Abstract][Full Text] [Related]
19. [Intratympanic corticosteroid perfusion in the therapy of Meniere's disease].
Sanković-Babić S; Kosanović R; Ivanković Z; Babac S; Tatović M
Srp Arh Celok Lek; 2014; 142(5-6):291-5. PubMed ID: 25033583
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]